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Abstract
In this study, chemically crosslinked gelatin microgels were incorporated into
dopamine-modified poly (ethylene glycol) (PEGDM) adhesive to form composite
bioadhesive with simultaneously improved adhesive property and bioactivity. Gelatin
microgel, with an average diameter of 53.6±14.2μm, was prepared with water in oil
emulsification

method

and

chemically

1-ethyl-3-[3-dimethylaminopropyl]carbodiimide hydrochloride

crosslinked
(EDC)

with
and

N-hydroxysuccinimide (NHS). Gelatin microgels were incorporated into PEGDM
adhesive precursor solution at 1.5wt%, 3.75wt% and 7.5wt%. The cure time of adhesive
reduced from 54 seconds to 37 seconds with increasing gelatin microgel content.
Additionally, the incorporation of the gelatin microgel also increased the crosslinking
density of the adhesive network as indicated by the reduced equilibrium water content
and increased elastic modulus based on compression testing. The compliance of
adhesive was not compromised with the increased crosslinking density, as the failure
strain showed no significant decrease from the compression testing result. Results from
oscillator rheometry indicated that both the storage and loss moduli of the adhesive
increased with increasing microgel content, which suggested that the microgels
increased both chemical and physical crosslinks in the adhesive architecture. The
increased physical crosslink indicated increased energy dissipation ability of the
10

adhesive. Lap shear adhesive test demonstrated that the addition of gelatin microgel
enhanced the adhesive property of adhesive. The adhesive property was increased 1.5-2
fold after the addition of gelatin microgel. In the in vitro degradation test, samples of
different formulation groups degraded gradually under a similar rate after soaked in the
phosphate buffer solution (pH=7.4) and incubated at 37ć. After 8 weeks samples were
completely degraded. The in vitro cell viability was tested with L929 mouse fibroblast
and the results showed no cytotoxicity in each test formulation. The in vitro cell
attachment experiment revealed an enhanced cell attachment and spreading of primary
rat dermal fibroblast on gelatin microgel containing PEGDM adhesive compared to the
adhesive without gelatin microgel. The results of rat subcutaneous implantation revealed
higher cell recruitment and collagen deposition compared with control adhesive group
which has no gelatin microgel in structure. Cell infiltration was found in the pocket
structure formed by the degradation of gelatin microgel. In conclusion, the incorporation
of gelatin microgel presents a simple method to simultaneously enhance the adhesive
property and bioactivity of bioadhesive.
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1. Introduction
Surgical sutures, staples and clips are traditionally used in wound closure and tissue
reconstruction. But these methods present many drawbacks such as causing chronic pain
and additional damage to wound.[1] Bioadhesives as an alternative choice has attracted
more and more attention during the past decades. It can be delivered with minimally
invasive method and gel in situ. The bioadhesives adhere to the native tissue and hold
the edges of the wound together to promote wound closure without introducing extra
damage and pain suffering. However, bioadhesives in the current market present many
limitations, such as the risk of disease transmission, poor adhesive strength (e.g., fibrin
glue)[2],

cytotoxicity

(e.g.,

cyanoacrylate

adhesive)

and

lacking

bioactivity

(poly(ethylene glycol) (PEG)-based adhesive).

Poly (ethylene glycol) (PEG)-based bioadhesives have been widely investigated due to
their tunable properties, cytocompatibility and bioinert property as well as high water
content which is similar to the extracellular environment of tissue.[3] However, the
bioinert property makes PEG-based adhesives resisting to the cell adhesion and lacking
interaction with surrounding cells to regulate the cell function.[4] Many studies have
been performed to investigate the method to improve the interaction between cell and
adhesives. For example, bioligands, such as cysteine-containing peptides or proteins,
12

have been tethered on the PEG structure to mimic the extracelluar matrix (ECM) and
interact with cell membrane receptor to modulate cell morphogenesis.[5] Other short
peptide sequences presenting in ECM protein, such as Arg-Gly-Asp (RGD)[6] and
Arg-Glu-Asp-Val (REDV)[7], are also used to promote cell adhesion and proliferation.
However, functionalizing PEG with bioactive peptide sequences requires multi-step
chemical synthetic approach, which is associated with low yield and high cost. Most
importantly, peptide-functionalization does not increase the mechanical properties of
these materials.

Gelatin is hydrolyzed from collagen which is the main component of ECM and contains
RGD sequence to promote cell adhesion, migration and proliferation.[8-11] Since it is
derived from ECM, it shows nontoxicity and biodegradability.[12] The physical network
of gelatin gel can easily break down at a higher temperature but the thermal and
mechanical stability can be improved through chemical crosslinking.[13] The application
of gelatin microgel has been reported in drug delivery[14] and tissue engineering[15]. Drug
molecule was loaded in the gelatin microgel and released after delivered into
physiological environment. Growth factor was also entrapped within the structure of
gelatin microgel to promote the tissue regeneration.

13

In this project, we combined biomimetic PEG-based adhesive with gelatin microgel to
prepare a novel bioadhesive with enhanced adhesive property and bioactivity. PEG is a
hydrophilic and biocompatible polymer that serves as the backbone of the adhesive. The
glutaric acid was linked with PEG through ester bond, which can be hydrolyzed in the
presence of water. Dopamine was modified on the end of PEGGlu structure. The
catechol groups can be oxidized by NaIO4 to form highly reactive quinones. The
quinones subsequently react with each other to form covalent bonds completing the
polymerization of adhesive (Figure 1-1A). Other quinones will react with amine groups
in the gelatin microgel structure to form covalent bonds (Figure 1-1B) or with other
functional groups in the tissue to form covalent bonds completing the adhesion to tissue
surface (Figure 1-1C).

Figure 1-1.1Schematic illustration of the reactions between dopamine-modified PEG and gelatin
microgelor native tissue. Catechol groups are oxidized to form reactive quinines A) the highly
reactive quinones interact with each other to complete the polymerization of adhesive; B) highly
reactive quinones interact with gelatin microgel to form covalent bonds; C) highly reactive quinones
14

interact with native tissue and form covalent bond.

1.1 Tissue adhesive

The application of tissue adhesive for wound closure can minimize the trauma, reduce
the operation time and effectively stop the leakage of body fluid. An ideal tissue
adhesive is expected to possess following properties.[16] First, an ideal tissue adhesive
should present sufficient flow characteristic when it is in the liquid state so that it can be
applied easily on the tissue surface. Second, the ideal tissue adhesive should be able to
solidify from liquid state rapidly under mild physiological condition. Third, after the
gelation the adhesive should maintain strong adhesion to the tissue and strong bulk
mechanical property during the healing phase. Finally, the adhesive should also be
biocompatible and sterilized easily without compromising its properties. Current tissue
adhesives can be classified into two categories: biological and synthetic adhesives.

Fibrin glue is a biological tissue adhesive and it has been investigated for decades.
Fibrin glue mimics the final stage of blood clotting.[2] Fibrinogen and thrombin are the
two main components involved in the process. By mimicking the blood clotting process,
fibrinopeptides are removed from fibrinogen under the mediation of thrombin. After the
removal of firbinopeptides, fibrinogen changes the conformational structure and
15

self-assemble into fibrin gel to adhere on the surrounding tissue. The fibrin gel provides
adhesion sites for cell migration and proliferation to promote the tissue regeneration.[17]
Additionally, it also presents advantages such as controllable degradation to precisely
match the rate of tissue regeneration, rapid hemostasis and excellent biocompatibility.[2]
The fibrin sealants have been successfully used in a number of surgical practices, such
as cardiovascular, neuro-, plastic, hernia repair

[18]

and liver surgeries[19]. However, the

fibrinogen and thrombin are obtained from blood which makes the fibrin sealants at a
risk of disease transmission. In addition, the relative low mechanical properties make
fibrin sealants undesirable as a tissue adhesive.

Cyanoacrylate adhesive (CA) is synthesized through the condensation polymerization of
cyanoacetate and formaldehyde.[20] It shows a relatively high bonding strength and has
been used in various applications, such as vascular repair[21, 22], hemostasis[23, 24] as well
as retinal repair[25]. The adhesive provides a water-resistant barrier for wound but a
constant exposure to body fluids may weaken the adhesive property.[26] Additionally, the
CA adhesive causes inflammation in vivo and is toxic to the cells in vitro. Cell damage
may be caused by the released heating during the polymerization process.[27]

Poly (ethylene glycol) (PEG)-based tissue adhesive is another important type of

16

synthetic adhesives. PEG-based tissue adhesive has been used in many biomedical
applications because of its biocompatibility, non-immunogenity, and bioinert
characteristics to resist cells or proteins adsorption.[28] Crosslinked oxidized
methacrylated alginate/PEG (OMA/PEG) hydrogel as bioadhesive has been studied by
Jeon et al. recently. It has been demonstrated that by changing the degree of alginate
oxidation, the swelling behavior, degradation and storage modulus of hydrogel
aretunable.[29] The adhesion strength of OMA/PEG is also superior to the commercial
fibrin glue. PEG end-functionalized with DOPA and its derivatives (e.g., dopamine,
3,4-dihydroxyhydrocinnamic acid) have been investigated as injectable tissue adhesive
and sealant.[30] These adhesives outperformed fibrin glue in various adhesion tests,
including lap shear, burst strength and peel adhesion tests. Brubaker et al.[31] endcapped
PEG with catechol groups, which is a functional groups in DOPA and its derivatives,
and used this novel tissue adhesive in extrahepatic islet transplantation. The adhesive
hydrogel cured in 1min and elicited minimal inflammatory response in mice.

1.2 DOPA

DOPA (3,4-dihydroxyphenylalanine) is a catechol-containing amino acid

(Figure 1-2)

which is found in the structure of mussel byssal plaque protein.[32] The byssus consists
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of plaques, threads, stem and root. The byssus threads are rapidly made of proteins and
radially distributed while attaching to the stem. The plaques are responsible for the
attachment to the outside surfaces. (Figure 1-3)

Figure 1-2.2Chemical structure of DOPA. A catechol group shows in the side-chain of the DOPA
structure.

Figure 1-3.3Image and schematic illustration of mussel structure. A) Adult mussel with radially
extended byssus attaching on a solid surface; B) Schematic representation of the mussel with byssus
consists of threads and plaques and attaches to the stem.[32] (Copyright permission documentation in
Appendix)
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The byssal plaques are believed to be responsible for the strong adhesive performance
due to the high content of unique mussel foot proteins (Mfp-2, -3, -4, -5 and -6), which
all contain DOPA. The catechol group of DOPA has the capability to undergo different
catechol-catechol or catechol-surface interactions (Figure 1-4). Catechol groups can
react with metal ions[33] (Figure 1-4A) or metal oxide surface[34] (Figure 1-4B) to form
reversible bond. Catechol groups can be oxidized into highly reactive quinones and react
with each other to complete the polymerization process[35] (Figure 1-4C). When
quinones react with natural tissue, covalent bonds can be formed with the functional
groups showing in the tissue, such as lysyl groups, cystainyl groups and histidyl
groups[36, 37] (Figure 1-5D). Lee et al.[36] investigated the single-molecule adhesion of
DOPA. The results suggested that the interaction between DOPA and wet inorganic
surface is strong (~800pN) and reversible. However, the interaction between DOPA and
amine-modified organic surface was dramatically higher than that between DOPA and
inorganic surface. The 2.2nN force was believed coming from the covalent bond formed
between catechol group and organic surface.
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Figure 1-4.4Schematic of catechol group reactions. A) catechol groups form reversible bond with
metal ion; B) catechol groups react with metal oxide surface to form reversible bond; catechol
groups oxidized into highly reactive quinones C) quinones react with each other to complete the
polymerization; D) or react with different functional groups showing on the tissue surface to form
covalent bond.

Recently, DOPA has been used to develop antifouling coatings[38-40] and tissue
adhesives[41,

42]

. A thermal-triggered gelation of DOPA-modified PEG hydrogel as

bioadhesive was studied by Burke et al.[30] The oxidizing reagent was entrapped in
liposome and released at body temperature. The hydrogel cured rapidly and showed a
potential for biomedical application. Choi and coworkers[43] used tyrosinase to oxidize
tyrosine residues in human gelatin into DOPA and they crosslinked the DOPA-modified
gelatin into hydrogel by adding Fe3+ ions. Both of the results from in vitro and in vivo
tests showed that DOPA-Fe3+ gelatin hydrogel exhibited good mechanical properties and
20

hemostatic properties indicating that it is a promising tissue adhesive for surgical
operations.

1.3 Poly(ethylene glycol)

Poly (ethylene glycol) is a polyether that can be easily synthesized into linear or
branched (4-armed, 6-armed, 8-armed and superbranched) architecture with different
molecular weights ranging from several hundred Da to ten million Da or more.[44] It is
synthesized from ethylene oxide through anionic polymerization (Figure 1-5).

Figure 1-5.5Synthesis of poly (ethylene glycol) from anionic polymerization of ethylene oxide.

PEG has been used in many biomedical applications because of its biocompatibility,
non-immunogenity and bioinert characteristics to resist cell or protein adsorption.[28, 45,
46]

It is believed that when proteins are getting closed to the PEG-surface, the repulsive

force is increased due to the decreased conformational freedom of the PEG chains. In
addition, the osmotic interaction between proteins and PEG-surface due to the steric
stabilization force will also repulse proteins from PEG-surface.[47] VigilonTM and
HypolTM are two PEG-based commercial products. VigilonTM is formed through the
21

radiation crosslinking of PEO and is used as wound cover material. HypolTM is a PEG
foam used in wound healing and drug delivery.[48] In recent years, PEG gel has also been
investigated as vehicles for protein delivery[49] and three dimensional scaffolds[50].
However, the bioinert nature of PEG makes it lacking biological activity.

Inspired by nature, researchers modified PEG to mimic the natural extracellular matrix
(ECM) and applied the modified PEG hydrogel in tissue engineering. RGD sequence is
the most effective and widely used peptide sequence to stimulate cell adhesion of
PEG.[51] RGD-mediated cell adhesion consists of four steps: cell attachment, cell
spreading, organization of actin cytoskeleton and formation of focal adhesion. Integrin
existing on the cell membrane binds with RGD ligand allowing cells to withstand shear
force and anchor at a specific location. After the cell attachment, integrin-RGD ligand
interaction is involved in the transmembrane signal transduction to regulate cell
response, such as proliferation, differentiation and apoptosis. RGD peptide gradient was
immobilized on the PEG scaffold to guide the cell migration.[52] Results revealed that
cells tended to migrate in the direction of gradient with a higher speed than on the
hydrogel with uniform distribution of RGD. PEG has also been modified with RGD
peptide sequence to facilitate the cell adhesion and promote bone tissue regeneration.[53]
There was a significant increase of mineralization after the introduction of RGD in the
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network of hydrogel.

1.4 Gelatin

Gelatin is a soluble protein hydrolyzed from collagen.[54] Both collagen and gelatin were
used in wound dressing and adhesives.[55] However, collagen expresses antigenicity in
physiological condition while gelatin is known having no such antigenicity.[56, 57] The
denature processes include the melting of ordered hydrogen bond and destroying of the
triple helix structure to produce random chains of gelatin molecule. Since gelatin is
obtained by hydrolyzing collagen which is the main component of ECM, it also contains
RGD-like sequence to promote cell adhesion, migration and proliferation.[58] There are
two types of gelatin: gelatin A, which is obtained by acidic pretreatment before
denaturation; gelatin B, which is processed by alkaline pretreatment. The alkaline
pretreatment leads to a higher content of carboxylic acid in gelatin B than that of gelatin
A.[59] Molecular chains of gelatin undergo a coil-to-helix conformational transition to
form physical thermo-reversible gels when the temperature of gelatin solution is lower
than 35ć, in which process the gelatin molecules tend to recover the triple helix
structure of collagen.[60, 61] However, the physical network of gelatin gel easily breaks
down

at

a

higher

temperature.1-ethyl-3-[3-dimethylaminopropyl]carbodiimide
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hydrochloride (EDC) and N-hydroxysuccinimide (NHS) are widely used chemical
crosslinking agent to improve the thermal and mechanical stability of gelatin gel.[13]
Under reaction of EDC and NHS, ̢COOH groups and ̢NH2 groups showing in the
gelatin molecule will form covalent bonds[62, 63] (Figure 1-6).

A photocurable tissue adhesive glue composed of photoreactive gelatin and
poly(ethylene glycol) diacrylate (PEGDA) was investigated by Nakayama et al.[64]
Gelatin was modified with photoreactive groups and combined with PEGDA. Under
exposure to the UV or visible light within 1min, water-swollen gels were produced and
these gels showed a high adhesive strength to wet collagen film. When applied on the
rat liver tissue, the gel tightly adhered to the native tissue through interpenetration and
the gel stopped bleeding completely. Balakrishnan et al.[65] reported a self-crosslinked
oxidized alginate/gelatin hydrogel as injectable biomimetic adhesive scaffold for
cartilage regeneration. In their experiment the hydrogel was delivered with a minimally
invasive injection and was cell-attractive. It functioned as an adhesive scaffold for the
treatment of osteoarthritis. The hydrogel integrated well with cartilage tissue and
showed a burst pressure of 70േ3 mmHg, indicating the adhesive nature. Vandelli et
al.[14] and Wu et al.[66] used crosslinked gelatin microgel as drug delivery vehicle. The
gelatin microgel was synthesized via water/oil emulsion system and chemically
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crosslinked. Drug molecule was loaded in the microparticle structure and released under
the physiological environment. Results of subcutaneous injection showed that gelatin
microgel exhibited good biocompatibility. Basic fibroblast growth factor incorporated
gelatin microgel was investigated by Kawai and colleagues to accelerate tissue
regeneration.[15] In the experiment the basic fibroblast growth factor incorporated gelatin
microgel was added into artificial dermis and implanted into full-thickness skin defects
on pig. The results showed that gelatin microgel impregnated with basic fibroblast
growth factor accelerated the fibroblast proliferation and capillaries formation.

Figure 1-6.6Schematic illustration of EDC/NHS involved chemical crosslinking.[62] –COOH and
–NH2 groups in gelatin structure form covalent bond to chemically crosslink the gelatin hydrogel
under the function of EDC and NHS. Reprinted with permission from [60]. Copyright (1999)
American Chemical Society. (Copyright permission documentation in Appendix)

1.5 Wound healing
25

Wound healing is a complex process requiring interaction of different cells and
tissues.[67] It consists of four steps: hemostasis, inflammation, proliferation, and
remodeling and scar tissue formation.[68] The formation and contraction of newly
formed connective tissue (granulation tissue) in step three is an essential step in wound
healing to keep the tissue continuity.[69] During the normal wound healing, the
inflammatory cells arrive to the wound bed first and followed by fibroblasts, which
starts the deposition of collagen and other matrix component.[70] The newly formed
connective tissue brings the edges of wound together through its contraction.
Subsequently, a decrease in the cell number happens in the granulation tissue and the
granulation tissue forms a poorly cellularized scar.[71] However, in many cases the cell
apoptosis does not occur and there is no scar tissue formed. Then granulation tissue
evolves into hypertrophic scar containing many myofibroblasts and inappropriately
produced extracellular matrix, which results in a deformation of surrounding connective
tissue. The deformation is considered as pathological issue. Therefore, it is very
important to control the newly formed connective tissue to develop into a normal and
functional tissue in the wound healing process.
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2. Experimental
2.1 Materials

Gelatin powder (Type A, 300 Bloom, from porcine skin) was purchased from Electron
Microscopy Sciences. Sodium periodate (NaIO4, ACS reagent>99.8%), pyridine (ACS
reagent, >99.0%),

1-ethyl-3-[3-dimethylaminopropyl]carbodiimide hydrochloride

(EDC), N-hydroxysuccinimide (NHS), Masson’s trichrome stain kit, bouin solution,
Weiger’s iron hematoxylin solution, TWEEN80 and glutaric anhydride were purchased
from Sigma-Aldrich. Dulbecco’s modified Eagle’s medium (DMEM) was obtained from
Corning Cellgro. Fetal bovine serum (FBS) was purchased from Thermo Scientific.
Sodium

pyruvate

(100mM),

MEM

non-essential

amino

acid

(100X)

and

4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) buffer solution (1M) were
purchased from Life Technologies. 8-arm poly (ethylene glycol) (20K) was purchased
from JenKem Technology. Dopamine hydrochloride was purchased from Acros
Organics.

O-(Benzotriazol-l-yl)-N,N,N’,N’-tetramethyluroniumhexafluorophosphate

(HBTU) and 1-hydroxybenzotryazole monohydrate (HOBt) were purchased from
Chem-Impex International. Phosphate buffer saline and N,N-dimethylformamide (DMF)
were purchased from Fisher Scientific. Chloroform was purchased from J.T

27

Baker.3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium

bromide

(MTT)

98%waspurchased from Alfa Aesar.4',6-Diamidino-2-phenylindole (DAPI) was
purchased from Invitrogen. Anti-S100A4 antibody (ab27957), goat anti-rabbit IgG H&L
(Alexa Fluor 488; ab150077), anti-CD11b antibody (ab8879) and goat anti-mouse IgG
(Alexa Fluor&reg; 488) (ab150113) were purchased from Abcam. Anti-CD163 antibody
(sc-58965) and goat anti-mouse IgG (sc-2781) were purchased from Santa Cruz
Biotechnology. Rat dermal fibroblast was isolated from rat dermal tissue and identified
with Anti-S100A4 antibody and goat anti-rabbit IgG H&L (Alexa Fluor 488).[72] 12-well
cell suspension culture plate was purchased from VWR International. Mechanical sieves
were purchased from ATM Corporation. Dialysis tubing was purchased from Spectrum
Labs (MWCO 3500).

2.2 Methods

2.2.1 Synthesis of dopamine-modified 8-arm PEG (PEGDM)

A two-step method was used to synthesize biodegradable dopamine-modified 8-arm
PEG. The first step was to link glutaric acid to the end of PEG structure.32g of 8-arm
PEG powder was combined with 7.30g glutaric anhydride in a round bottom flask and
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dissolved in 300mL chloroform and 5.16mL pyridine under nitrogen. The solution was
refluxed under nitrogen for 24h. After which, most of the solvent was removed by rotary
evaporation followed by the complete removal of the solvent in the vacuum system. The
polymer was further dialyzed for 48h (pH around 3.0) to remove the unreacted
molecules. The sample was then freeze-dried and characterized with nuclear magnetic
resonance (NMR). The coupling efficiency was 81%, which was determined using
NMR. The yield of product was 30g. 1H NMR (400MHz, D2O) δ 3.75-3.39 (m, PEG),
2.37 (t, 2H, -C(=O)-(CH2)2-CH2-C(=O)-), 2.32 (t, 2H, -C(=O)-(CH2)2-CH2-C(=O)-),
1.79 (t, 2H, -C(=O)-(CH2)2-CH2-C(=O)-). (Figure A1 in Appendix)

To add dopamine molecule on the structure of PEG-glutaric acid (PEGGlu), 30g
PEGGlu sample was combined with 5.45g dopamine HCl, 3.70g HOBt and 9.16g
HBTU. The mixture was dissolved in 120mL of chloroform, 60mL of DMF and 4.01mL
of triethylamine. After reacting for 3h the solution was rotary evaporated and completely
dried in vacuum. Dialysis was performed for 48h (pH around 3.0) to remove the
unreacted small molecules. The freeze-dried sample was characterized with NMR. The
coupling efficiency was 80% which was determined using NMR. The yield of the
product was 27.58g. 1H NMR (400MHz, D2O) δ 6.71 (d, 1H, -C6H2H(OH)2), 6.64 (d,
1H, -C6H2H(OH)2), 6.56 (d, 1H, -C6H2H(OH)2), 3.74-3.38 (m, PEG), 2.12 (t, 2H,
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-C(=O)-(CH2)2-CH2-C(=O)-), 2.07 (t, 2H, -C(=O)-(CH2)2-CH2-C(=O)-), 1.67 (t, 2H,
-C(=O)-(CH2)2-CH2-C(=O)-).(Figure A2 in Appendix)

2.2.2 Preparation of gelatin microgel

2g of gelatin powder was dissolved in 20mL of deionized water (DI water) in 50-55ć
water bath. The solution was stirred with magnetic stir bar in water bath at 50-55ć for
10min. The gelatin solution was added dropwise into 200mL preheated olive oil under
stirring at 1000 rpm in 50-55ćwater bath for 1h to form an emulsion. The temperature
of the emulsion was lowered to room temperature and the emulsion was kept stirring for
30min. In order to continue solidifying the gelatin microgel, the container of reaction
system was placed in ice water bath for 30min to lower the temperature. 100mL
precooled acetone (4ć) was added into the emulsion mixture to wash the microgel for
30min in ice water bath. The overhead stirrer kept stirring until the end of wash step.
The microgel was separated from olive oil and acetone through vacuum filtration. The
separated microgel was washed twice in 60mL precooled acetone. The size distribution
was controlled in the range of 53-75μm using the mechanical sieves and the microgel
was stored at 4ć. The yield of produced microgel was 0.72f0.05g.
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In order to chemically crosslink the gelatin microgel, 0.5g of microgel was suspended in
30mL of phosphate buffer saline (PBS) (pH=5.7, 0.5% TWEEN 80). 0.134g of EDC and
0.02g of NHS were added into the microgel suspension to start the crosslink reaction.
The reaction mixture was kept at 4ć for 24h. After which, the microgel was washed
twice with 60mL of precooled (4ć) acetone to remove EDC and NHS and the reaction
was stopped. The Crosslinked microgel was collected with vacuum filtration and the dry
product was stored at 4ć. The yield of the crosslinked microgel was 0.43f0.02g. The
morphology of gelatin microgel was characterized with scanning electron microscope
(SEM).

2.2.3 Preparation

and

characterization

of

gelatin

microgel

incorporated PEG (PEG-GM) adhesive

Gelatin microgel was suspended in polymer precursor solution containing PEGDM
(30wt% PEGDM and 0-15wt% gelatin microgel) in 10mM PBS buffered at pH 7.4. The
PEG-GM adhesive was prepared by mixing equal volumes of PEGDM/microgel
mixture and NaIO4 solution (11.67mg/mL in DI water). The molar ratio of NaIO4 and
dopamine was 0.5 and the final concentrations of PEGDM and gelatin microgel were
15wt% and 0-7.5wt%, respectively. The cure time was determined when the mixture
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stopped to flow in a tilt vial (Figure 2-1).[73] The adhesives used in the following
experiments were allowed to cure for 12h and were cut into dish shape. The dish-shaped
adhesives were equilibrated in PBS (pH 7.4) for the following tests.

Figure 2-1.7Image of the experiment to determine the cure time of adhesive. The cure time was
determined when the adhesive solution stopped flow in a tilt vial. 8

Adhesive samples with (7.5wt%) and without (0wt%) gelatin microgels were
vacuum-dried for 2 days. Fourier transform infrared spectroscopy (FTIR) was
performed using a PerKinElmer Spectrum One Spectrometer to obtain the FTIR spectra
of dry samples.

Adhesive samples (n=4) with 0wt%, 1.5wt%, 3.75wt% and 7.5wt% gelatin microgel
were equilibrated in PBS (pH=7.4) at room temperature overnight. The mass of swollen
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samples (Ms) were weighed after the equilibration. Samples were then vacuum-dried for
2 days to obtain the dry mass of adhesives (Md). The equilibrium water content (EWC)
was determined by equation of:

EWC = (Ms–Md)/Ms×100%

(Equation 1)

2.2.4 Mechanical properties

2.2.4.1 Compression test

6 pieces of adhesive disc samples of each formulation (0wt%, 1.5wt%, 3.75wt% and
7.5wt%) were tested. The dimensions of the samples were ~3mm in thickness and
~7mm in diameter, measured individually with a digital caliper. The samples were
compressed using Bose ElectroForce mechanical testing machine at a rate of
0.03mm/second until the adhesive structure completely fractured. The stress was
calculated by dividing the load measured by the surface area of the sample. The strain
was obtained by dividing the place changes of compression plate by the original
thickness of the sample. The failure stress and failure strain were determined when the
first fracture occurred. Toughness was determined by the integration of the area under
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the stress-strain curve. The elastic modulus was determined based on the slope of the
stress-strain curve at a strain between 0.05 and 0.12.

2.2.4.2 Oscillatory rheometry

The storage (G’) and loss (G’’) modulus was determined under frequency of 0.1-100 Hz
at stain of 0.1 using a rheometer (HR-2, TA Instruments, New Castle, DE). Adhesive
discs (diameter= 8 mm, thickness = 1 mm, n = 3) were tested using parallel plates at a
gap distance that is set at 85% that of the individual adhesive thickness, as measured by
a digital venire caliber.

2.2.5 Lap shear test

Adhesive property of PEG-GM adhesive was tested according to the American Society
for Testing and Materials (ASTM) standard F2255-05. 60μL of PEG polymer precursor
solution and 60μL of NaIO4solutionwere added onto the overlap area of two pieces of
bovine pericardium and cured in situ with an overlap area of 2.5cm x 1cm. A 100g
weight was immediately loaded on the top of overlapping area for 10min (Figure 2-2).
After the complete gelation, samples were placed in the PBS solution and incubated at
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37ćovernight. The adhesive area of each sample was measured in both length and
width before the testing with a digital caliper. The samples were pulled at a rate of
5mm/min until completely separated. The adhesive strength and the work of adhesion
were obtained respectively by dividing the max load and the integral of the area under
the load-displacement curve by the adhesive area measured before the test.[74]

Figure 2-2.9Photographs of preparation for lap shear test. A) One piece of bovine pericardium placed
in a mold; B) the other piece of bovine pericardium placed on a glass slide; C) adhesive precursor
solutions was mixed in the overlap area; D) the mixed precursor solution covered by the other piece
of bovine pericardium; E) 100g weigh loaded on the overlap area for 10min.

2.2.6 In vitro degradation test

PEG-GM adhesives containing 0wt%, 1.5wt%, 3.75wt% and 7.5wt% gelatin microgel
were punched into disc shape (thickness=1mm, diameter=8mm) and incubated in 2mL
PBS at 37ć. PBS was changed every 7 days. Three pieces of adhesive were dried in
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each formulation group and recorded the dry weight of adhesive. M0 is the average dry
weight of adhesive at original status. Three repeat samples in each formulation group
were then collected every week and dried to weigh the weight of adhesive to determine
the remaining mass after degradation, Mt. The degradation was determined by:

Degradation%=Mt/M0× 100%

(Equation 2)

2.2.7 Cell experiment

2.2.7.1 Cell viability

In order to evaluate the cytotoxicity of PEG-GM adhesive, quantitative MTT
cytotoxicity assay according to the ISO 10993-5 guideline was conducted. L929 mouse
fibroblast was cultured in culture medium containing 10% FBS and 10 units/mL
penicillin-streptomycin in DMEM at 37ć.Adhesive extract was obtained by incubating
the adhesive discs in the culture medium for 24h and using 0.22μm sterile filters to
sterilize the adhesive extract[75]. Meanwhile, cells were seeded into 96-well culture plate
at the density of 1x104 cell/cm2. Each well was then added 100μL of culture medium
and incubated for 24h to obtain a confluent monolayer of cells. After 24h the cell culture
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medium was removed and 100μLadhesive extract was added into each well. The
adhesive extract was then replaced by 50μL MTT solution (1mg/mL in PBS) after 24h
incubation and continued to incubate for another 2h. 100μL DMSO was added into each
well to replace the MTT solution. The absorbance was measured at 570nm with a
Synergy HT Multi-Mode Microplate Reader (BioTek, USA). Three tests were repeated
for each formulation group. The relative cell viability was calculated with:

Cell viability% = Aadhesive/Acontrol× 100%

(Equation 3)

Where Aadhesive is the absorbance for cells cultured in adhesive extract and Acontrol is the
absorbance for cells cultured in cell culture medium. The test was repeated for three
times for each formulation (0wt%, 3.75wt% and 7.5wt%). Samples were considered
non-cytotoxic when they had a relative cell viability higher than 70%.[75]

2.2.7.2 Cell attachment

PEG-GM adhesives containing 0wt%, 3.75wt% and 7.5wt% gelatin microgel were
punched into dish shape (thickness=0.5mm, diameter=10mm). Adhesive samples were
sterilized with 70% ethanol for 45min and balanced with PBS for three times, each time
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lasting30min.[75] Rat dermal fibroblasts with a density of 3.2 x 104 cell/cm2 were seeded
on the surface of adhesive samples in a 12-well cell suspension culture plate. The cells
were seeded on the surface of adhesive for 30min in an incubator and subsequently
cultured for another 72h at 37ć.Cell density was quantified using ImageJ software after
the DAPI staining. Calcine and ethidium bromide were diluted in PBS at 1: 1000 ratio.
Cells were incubated in the calcine/ethidium bromide solution for 3min. The cell
morphology was observed by calcine staining. The calcine-stained cells were considered
as living cells which have been successfully attached on the adhesive and continue to
proliferate.[76] Ethidium bromide-stained cells were considered as dead cells.

2.2.8 Subcutaneous implantation

Healthy, weight matched Sprague Dawley rats were provided by Michigan
Technological University animal care facility. The subcutaneous implantation was
performed following the protocol approved by Michigan Technological University
Institutional Animal Care and Use Committee. Disc-shaped PEG-GM adhesives
containing 0wt% and 7.5wt% gelatin microgel (diameter=10mm and thickness=1.5mm)
were subcutaneously implanted. Each formulation has four pieces of repeat sample.
Samples were sterilized using ethanol-based sterilization method (samples were soaked
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in 20mL 70% ethanol for 45min and washed with 20mL PBS for 30min for three
times[75]) Rats were anesthetized with isofluorane-oxygen gas. Fur in the surgical area
was removed and surgical sites were sterilized with ethanol and betadine. Four bilateral
pouches were formed with sterile surgical scissors on the back of rats. Samples were
implanted into the pouches. Wounds were closed with surgical staples. After 2 weeks
and 6weeks recovery, rats were sacrificed. Samples and surrounding tissue were
collected and flash frozen in Polyfreeze for the following cryosection. Samples were
sectioned into 10μm thick sections and stained with Hematoxylin and eosin (H&E)
staining and Masson’s trichrome staining to evaluate the morphology and collagen
formation, respectively. Fibroblast marker S100A4, M1 macrophage marker CD11b and
M2 macrophage marker CD163 were used for immunohistochemistry staining to
analyze the inflammatory response and wound healing process.[75, 77, 78] All images were
taken with Olympus microscope and analyzed with ImageJ software.

2.2.9 Statistical analysis

Statistical analysis was performed using SigmaPlot software. Student t-test and one-way
analysis of variance (ANOVA) were used to compare the means of two groups and
multiple groups, respectively. A statistical difference was determined when p-value was
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less than 0.05.

3. Results and discussions
3.1 Preparation and characterization of materials

Gelatin microgel was synthesized via water in oil emulsification method.[14] The surface
morphology of harvest gelatin microgel was characterized using SEM (Figure 3-1) and
the average diameter of gelatin microgel was 53.57f14.23μm.

Gelatin microgel incorporated PEG adhesive was prepared with a simple operation
under mild condition. Microgels were suspended into PEG precursor solution at room
temperature first. Then the gelatin microgel containing PEG precursor solution and the
NaIO4 solution were fully mixed at room temperature and gelled in a minute. The cure
time of PEG-GM adhesive decreased with increasing weight percentage of gelatin
microgel (Figure 3-2). The average cure time of 0wt% PEG-GM adhesive was 54
second and the cure time decreased gradually with increasing weight percentage of
gelatin microgel. The 7.5wt% PEG-GM adhesive exhibited the shortest gelation time
(37 seconds). PEGDM adhesive cures through the polymerization of catechol groups in
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the dopamine structure with the introduction of the chemical oxidant (NaIO4).[73, 79]
Additionally, quinones which are oxidized from catechol groups can form covalent bond
with –NH2 found on the gelatin microgel surface.[36] As such, the number of cohesive
chemical crosslinks needed for network formation was reduced with increasing microgel
content, and resulted in a reduced cure time. A similar result was reported by Liu et al.[75]
that

the

incorporation

of

nanoparticles

decreased

the

gelation

time

of

dopamine-modified PEG adhesive.

For comparison purposes, we attempted to incorporate gelatin polymers into PEGDM
adhesive by directly blending it into the precursor solution. However, at the
concentrations that were tested in this study, gelatin was not soluble in the precursor
solution at room temperature. In order to dissolve gelatin, the temperature of the
precursor solution needed to be raised to above 50ć, but the mixture solidified upon
cooling as a result of physical bond formation within the gelatin polymer chains. This
temperature dependent curing of gelatin made it not possible to create an in situ curable
adhesive through direct blending of gelatin polymer.

Fourier transform infrared spectroscopy (FTIR) was used to confirm the incorporation
of gelatin microgel into PEGDM adhesive (Figure 3-3). FTIR spectrum contains peaks
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for ether bond (1000-1150 cm-1), ester bond (1731 cm-1), phenols (3200-3500 cm-1) and
aromatics (1400-1500 cm-1) of PEGDM and amide bond peaks (1568 and 1640cm-1) of
PEGDM and PEG-GM. The intensity of amide bond peak increased with the
incorporation of gelatin microgel while the intensity of ester bond remained unchanged,
confirming the incorporation of gelatin microgel into PEG adhesive.

Equilibrium water content (EWC) was measured to determine the physical property of
the adhesive network. The value of EWC is inversely proportional to the crosslink
density of adhesive network.[80] As shown in the Figure 3-4 EWC decreased from
90.1%f0.4% to 86.6%f0.5% with increasing content of gelatin microgel, which
indicated that the crosslink density of adhesives increased significantly with increasing
content of gelatin microgel.
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Figure 3-1.10SEM image of gelatin microgel.

Figure 3-2.11Cure time of PEG-GM adhesive with different gelatin microgel weight percentage. The
cure time decreased with the increasing weight percentage of gelatin microgel. * p < 0.05 when
compared with 0wt% adhesive.
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Figure 3-3. 12FTIR results of PEGDM adhesive (black) and PEG-GM adhesive (red).

Figure 3-4.13Equilibrium water content of PEG-GM adhesive with different gelatin microgel weight
percentage. The equilibrium water content decreased with increasing weight percentage of gelatin
microgel. * p < 0.05 when compared with 0wt% adhesive; # p < 0.05 when compared with 1.5wt%
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adhesive; $ p < 0.05 when compared with 3.75wt% adhesive.

3.2 Mechanical property test

3.2.1 Compression test

From unconfined, uniaxial compression test, incorporation of gelatin microgel increased
the elastic modulus of PEG-GM adhesive while other parameters such as the maximum
strength, failure strain and toughness were unaffected (Table 3-1). The increase in the
measured modulus corresponded with increased crosslinking density of PEG-GM,
which corroborated with results from EWC. The increased crosslinking density led to a
stiffer adhesive. However, the crosslinked bulk gelatin gel showed a significantly lower
modulus compared to those of PEG-GM adhesives (Table A1 in Appendix). Since the
failure strain showed no significant decrease with increasing content of gelatin microgel.
Therefore, the compliance of adhesive was not compromised with the increased
stiffness.
Table 3-1. 1Compression test results of 0wt%, 1.5wt%, 3.75wt% and 7.5wt% PEG-GM adhesive.

Failure stress/kPa

0wt%

1.5wt%

3.75wt%

7.5wt%

407f49.9

460f37.8

450f36.4

423f28.4
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Failure strain

0.64f0.03 0.62f0.02

0.60f0.01

0.57f0.03

Elastic modulus/kPa

151f10.0

161f5.1

177f15.1* 204f11.1*,#

Toughness/kJ/m3

183f11.5

199f8.2

193f17.7

196f37.7

* p < 0.05 when compared with 0wt% adhesive; # p < 0.05 when compared to 1.5wt% and 3.75wt%
adhesives

3.2.2 Oscillatory rheometry

The viscoelastic property of adhesive was determined through the oscillatory rheometry
test. The storage modulus (G’) was significantly higher than the loss modulus (G’’) in
all groups (Figure 3-5), indicating that the adhesive were fully crosslinked. The G’ of
0wt% sample (control group) was independent of frequency at a frequency less than
25Hz, which also indicated a chemically crosslinked network. On the other hand, there
was a slightly increase in G’ values with increasing frequency for microgel incorporated
samples, which indicated the presence of reversible physical bonds in the adhesive
network.[81] G’ values increased sharply for all the samples tested at elevated frequencies
(>25 Hz). This stiffening phenomenon is a typical behavior of chemically crosslinked
network, associated with polymer chains not having sufficient time to relax.[82]

The increased G’ with the increasing content of gelatin microgel indicates a higher
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crosslink density due to the presence of gelatin microgel. The catechol groups showing
in the PEG adhesive structure reacted with gelatin microgel and formed chemically
crosslinking. This matches the increased elastic modulus in compression test. Both of
these two results indicate a stiffer material with a higher content of gelatin microgel.

G’’ values also increased with the increasing content of gelatin microgel. Most
noticeably, the adhesive containing 7.5wt% microgel exhibited a G” value that was over
an order of magnitude higher than those of formulations containing 0wt% and 1.5wt%
microgel. The elevated G’’ revealed an increased viscous dissipation ability of
adhesive.[83] Molecular chains of gelatin undergo a coil-to-helix conformational
transition to form physical thermo-reversible gels at a lower temperature (< 35ć), in
which process the gelatin molecules tend to recover the triple helix structure of
collagen.[60, 61] The reversible physical bonds existing in the gelatin microgel and the
hydrogen bond in the adhesive network can be sacrificed before the breaking of
chemical bond during the energy dissipation.
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Figure 3-5.14Storage and loss modulus of PEG-GM adhesive. The storage modulus and loss modulus
increased with the increasing weight percentage of gelatin microgel.

3.3 Lap shear test

As shown in the figure 3-6, the adhesive strength and the work of adhesion of PEG-GM
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adhesives were significantly higher (1.5-2 folds) than the control group (0wt%). The
increased work of adhesion was attributed to the reversible physical bonds in the
adhesive structure, such as the physical bond existing in the gelatin microgel structure.
PEG-GM adhesive presented 2-fold higher work of adhesion due to the existence of
gelatin microgel compared with the dopamine-modified PEG hydrogel incorporated
with inorganic nanoparticle[75]. But the adhesive property reported here is weaker than
those in other studies of catechol-modified PEG systems.[30, 78] It is difficult to compare
this result with those in other studies due to the usage of different tissue and the testing
protocols (different methods used to prepare testing samples, strain rate, etc.).

Figure 3-6.15Lap shear adhesion test results of PEG-GM adhesive with different weight percentage
of gelatin microgel. * p < 0.05 when compared to0wt% adhesive. # p < 0.05 when compared to
1.5wt% adhesive.
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3.4 In vitro degradation test

In the in vitro degradation test, adhesives with different weight percentage of gelatin
microgel degraded at a similar rate (Figure 3-7). The degradation went slowly in the first
6 weeks and all the gels lost their 70% mass after 8 weeks. After 8 weeks all the
adhesives were completely degraded. There is no significant difference between
different testing groups, indicating that degradation occurred mainly through the
hydrolysis of the ester bond between the PEG and glutaric acid. The fast degradation
after 8 weeks was attributed to the loose structure of adhesive and more water molecule
penetrated into the adhesive structure to complete the degradation.

Figure 3-7.16In vitro degradation test of PEG-GM adhesives containing 0wt%, 1.5wt%, 3.75wt%
and 7.5wt% gelatin microgels.
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3.5 Cell experiment

3.5.1 Cell viability

MTT assay was performed to evaluate the cytotoxicity of PEG-GM adhesives (0wt%,
3.75wt% and 7.5wt%). The relative cell viability showed no significant difference
between the control group (0wt%) and test groups (3.75wt% and 7.5wt%) (Figure 3-8).
All the results of the three groups were higher than 70% which is considered as
biocompatible and noncytotoxic. The catechol modified PEG hydrogels previously
studied either in our lab or other investigators all presented as biocompatible and
noncytotoxic.[75,

78, 79, 84]

Additionally, gelatin is biocompatible and its degradation

product is also nontoxic.[14] Therefore it can be concluded that PEG-GM adhesive was
noncytotoxic.
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Figure 3-8.17Relative cell viability test results of PEG-GM adhesives containing 0wt%, 3.75wt%
and 7.5wt% gelatin microgel.

3.5.2 Cell attachment

Primary rat dermal fibroblasts were seeded on the surface of PEG-GM adhesive and the
cellular density of the attached cells was quantified after DAPI staining (Figure A3 in
Appendix). The cell number increased significantly with increasing weight percentage
of gelatin microgel. The number of attached cell on the 7.5wt% was about 4-fold higher
than control group (0wt%) and 2-fold higher than 3.75wt% group (Figure 3-9). Calcine
and ethidium bromide were used to stain living (green) and dead (red) cells, respectively
(Figure 3-10). The live/dead staining results showed that the ratio of living and dead
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cells was 1f0.25/3f0.47 on the 0wt% group and the living cells appeared rounded in
shape indicating that these cells were not attached well (Figure 3-10A)[76]. More cells
attached and spread on the 3.75wt% adhesive, although there were some cells in
rounded shape (Figure 3-10B). Most cells on the 7.5wt% adhesive were spread well
(Figure 3-10C). No dead cells were found on the 3.75wt% and 7.5wt% adhesives.
Gelatin microgels were also stained green through non-specific binding (blue arrows in
Figure 3-10 B and C), and there is evidence for co-localization of the attached cells and
the underlying gelatin microgels (Figure 3-10 B and C). The figures of DAPI staining
(Figure A3 in Appendix) also support the co-localization of attached cells and gelatin
microgels.

All the results discussed above indicated that the incorporation of gelatin microgel
promoted cells attachment and spreading, both of which are essential for the cell
survival and proliferation.[85-87] The gelatin microgel provided cell binding sites (i.e.,
RGD peptide sequences)[51, 53] and increased gelatin microgel content promoted cell
attachment and spreading. Additionally, as reported by Discher et al.[88] and Yeung et
al.[89] fibroblasts tend to spread on a stiffer substrate. This can also explain the
difference among these three testing groups.
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Figure 3-9.18Cell attachment result. The number of attached rat dermal fibroblasts on the adhesive
increased with the increased weight percentage of gelatin microgel.* p < 0.05 when compared to
0wt% adhesive. # p < 0.05 when compared to 3.75wt% adhesive.
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Figure 3-10.19Live/dead staining result of cell attachment test. Cells spread better with increasing
weight percentage of gelatin microgel. A: 0wt% adhesive; B: 3.75wt% adhesive; C: 7.5wt% adhesive.
Living cells were stained in green and dead cells were stained in red. Gelatin microgels were also
stained into green through non-specific binding. Blue arrow: gelatin microgel; Red arrow: spread
cells; Orange arrow: dead cells; Yellow arrow: Living cells but not spread.

3.6 Subcutaneous implantation

PEG-GM adhesives with 0wt% and 7.5wt% gelatin microgel were subcutaneously
implanted into rats for 2 and 6weeks to evaluate the in vivo biocompatibility and
bioactivity of the adhesive. The H&E and Trichrome staining revealed that after 2 weeks
of implantation, more cells were present near the tissue-adhesive interface of 7.5wt%
adhesive(7.7±0.9 cells/mm2) than 0wt% adhesive(5.3±0.8 cells/mm2) (Table 3-2 and
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Figure 3-11 A-D). Through the immunofluorecentstaining M1 macrophage and
fibroblast were observed in the tissue-adhesive interface (Figure 3-11 E and F, I and J),
while M2 cells were found further away from the tissue-adhesive interface (Figure 3-11
G and H). The results of 6 weeks of implantation showed higher cell density in
tissue-adhesive interface of 7.5wt% adhesive (3.4±0.64 cells/mm2) than that of 0wt%
adhesive (2.02±0.66 cells/mm2) (Figure 3-12 A and B). However, when compared to the
2 weeks test result, the cell density of 6 weeks test was obviously lower (Table 3-2). The
thickness of collagen deposition around 7.5wt% adhesive (74.31±14.14 μm) was also
higher than that surrounding the 0wt% adhesive (43.63±14.4μm) after 6 weeks of
implantation (Figure 3-12 C and D). Fibroblast and macrophage were observed in the
same area as the result of 2 weeks implantation (Figure 3-12 E-J). Cell infiltration into
the pocket structure via the degradation of previously contained gelatin microgel (single
headed arrows in Figure 3-11 and 3-12) was observed at both time points. However, the
pocket structure after 6 weeks of implantation is not as clear and regular as that of 2
weeks implantation due to the degradation of surrounding PEGDM adhesive. The
degradation of PEGDM adhesive resulted in an irregular and uneven tissue-adhesive
interface. Additionally, no cell infiltration into the pocket structure was observed in the
results of 2 weeks and 6 weeks implantation of control groups (0wt%). There was no
significant difference on the average infiltration layer thickness between control group
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and 7.5wt% group after 6 weeks of implantation (Table 3-2).

M1 macrophage was the predominant cell type found in the tissue-adhesive interface
area in both 2 weeks and 6 weeks test for 0wt% and 7.5wt% adhesives, indicating an
inflammatory response due to the degradation of materials.[4, 90] The degradation of both
PEGDM and gelatin microgel will lead to an uneven surface which will subsequently
induce inflammatory response surrounding the implanted materials. The higher cell
density in the interface of gelatin microgel containing adhesives is due to the activation
of macrophage by gelatin.[91, 92] Fibroblasts were then attracted by the macrophage and
started the deposition of collagen molecule.[93] The higher deposition of collagen
molecule surrounding the 7.5wt% adhesive after 6 weeks can be potentially used in the
wound healing of connective tissue. However, in order to achieve a successful and
normal wound healing process of connective tissue we need to further control the
collagen matrix formation into a normal and functional tissue.[70, 71] The presence of M2
macrophage indicated a wound healing process.[94]

Based on the discussion above, although there was M1 macrophage existing around the
adhesives, the cell density was significantly reduced after 6 weeks implantation
compared to 2 weeks implantation, indicating a reduced inflammatory response. The
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deposition of collagen and the existence of M2 macrophage are signs of wound
healing.[68,

94-97]

Therefore,

the

PEG-GM

adhesive

can

be

considered

as

biocompatible.[98] The cell infiltration into the pocket structure via the degradation of
gelatin microgel was observed in both 2 weeks and 6 weeks tests, indicating that gelatin
microgel can be degraded by cells and it can provide space for cell infiltration. However,
there was no significant difference in the cell infiltration layer of both 0wt% and 7.5wt%
groups after 6 weeks implantation, indicating that the degradation rates of both groups
were similar and the degradation was dictated by the hydrolysis of ester bond between
PEG and glutaric acid. Additionally, although cells could infiltrate into the pocket
structure after the degradation of gelatin microgel, cell infiltration was still prevented by
PEG adhesive. The results revealed that gelatin microgel containing PEG adhesive had
the potential to promote cell infiltration if we could build a pathway with gelatin
microgel for cells to go through the PEG adhesive.
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Figure 3-11.20Hematoxylin and eosin stain (H&E stain) (A and B), Masson’s Trichrome stain (C and
D) and immunofluorecent stain (E-J) of 0wt% and 7.5wt% adhesive and surrounding tissue after 2
weeks subcutaneous implantation. a: adhesive; Orange box: cell distribution area. Single headed
arrow: cell infiltrating into the pocket formed via gelatin microgel degradation. Blue (DAPI): cell
nuclei; Green (CD11b): M1 macrophage; Red (CD163 and S100A4): M2 macrophage and fibroblast,
respectively.
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Figure 3-12.21Hematoxylin and eosin stain (H&E stain) (A and B), Masson’s Trichrome stain (C and
D) and immunofluorecent stain (E-H) of 0wt% and 7.5wt% adhesive and surrounding tissue after 6
weeks subcutaneous implantation. a: adhesive; Orange box: cell distribution area. Single headed
arrow: cell infiltrating into the pocket formed via gelatin microgel degradation. Double headed
arrow : cell infiltration layer (IL in A and B) and collagen layer (CL in C and D), respectively. Blue
(DAPI): cell nuclei; Green (CD11b): M1 macrophage; Red (CD163 and S100A4): M2 macrophage
and fibroblast, respectively.
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Table 3-2. 2Cell density, cell infiltration layer and collagen layer thickness of 2 weeks and 6
weeks subcutaneous implantation.
2 weeks

6 weeks

0wt%

7.5wt%

0wt%

7.5wt%

5.3±0.8

7.7±0.9*

2.02±0.66

3.4±0.64*

Cell infiltration layer (μm)

-

-

95.79±14.37

97.15±16.78

Collagen layer thickness

-

-

43.63±14.47

74.31±14.14*

Cell density in tissue-adhesive interface
3

2

(x10 cells/mm )

(μm)

* p < 0.05 when compared to 0wt% adhesive.

4. Conclusion

This study has demonstrated that PEG-GM adhesive presented improved adhesive
property and enhanced bioactivity. PEG is known for its biocompatibility but the
bioinert property makes it lacking of interaction with surrounding cells to regulate the
cell function and tissue development.[4] The incorporation of gelatin microgel provided
the cell binding sites to promote the bioactivity. In addition, the gelatin microgel reacted
with PEGDM to form both chemical and physical bond to increase the bulk property of
material. The incorporation of chemically crosslinked gelatin microgel into PEGDM
also enhanced the mechanical stability of gelatin. The increasing weight percentage of
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gelatin microgel contributed to a faster gelation of adhesive and showed stronger
adhesive property under wet environment. The in vitro degradation test showed no
significant difference among the adhesives with or without gelatin microgels, indicating
that the adhesives degraded through the hydrolysis of ester bond between PEG and
glutaric acid. Cell culture tests showed the PEG-GM adhesive as biocompatible and the
addition of gelatin microgel enhanced the cell attachment and spreading on the adhesive
surface. In vivo subcutaneous implantation test revealed that PEG-GM adhesive as
biocompatible and bioactive. The higher deposition of collagen molecule made the
PEG-GM adhesive a promising material for the wound healing of connective tissue.

In conclusion, incorporating gelatin microgel into PEGDM adhesive is a simple method
to achieve an adhesive presenting enhanced adhesive property and bioactivity.

5. Future work

Although cell infiltration can be observed in the present study, it is limited by the
absence of efficient pathway for cell going through. In the future work it is possible to
build an efficient pathway to further promote the cell infiltration. It is known that the
stiffness of cell adhesion substrate will influence the cell response on the morphology
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and adhesion.[88, 89] By changing the concentration of EDC and NHS the crosslinking
density of gelatin gel can be controlled.[62] It is possible to control the cell response
better through controlling the stiffness of gelatin microgel. We can also entrap growth
factor molecule within the gelatin microgel. With the degradation of gelatin microgel,
growth factor can be released to control the formation of normal and functional tissue. It
is also necessary to build a new animal model to study the material as an injectable
bioadhesive on tissue regeneration and wound healing.
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Appendix

Figure A1. NMR spectrum of PEGGlu.
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Figure A2. NMR spectrum of PEGDM.

Figure A3. DAPI staining of rat dermal fibroblasts for cell attachment test. A) 0wt% adhesive; B)
3.75wt% adhesive; 7.5wt% adhesive. Small blue dots: cell nuclei; Large cyan dots: gelatin
microgels.
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Table A1. Compression test results of crosslinked bulk gelatin gel.

Failure stress Failure strain Elastic modulus Toughness
kPa
kPa
kJ/m3
563±51.5

0.53±0.03

128±9.8
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218±6.3

Copyright permission for Figure 1-3

75

Copyright permission for Figure 1-6

76

